Current Protein & Peptide Science
Title: Editorial [ Immune Receptors for Glycoconjugates Guest Editor: Dapeng Zhou ]
Volume: 7 Issue: 4
Author(s): Dapeng Zhou
Affiliation:
Export Options
About this article
Cite this article as:
Zhou Dapeng, Editorial [ Immune Receptors for Glycoconjugates Guest Editor: Dapeng Zhou ], Current Protein & Peptide Science 2006; 7 (4) . https://dx.doi.org/10.2174/138920306778018043
DOI https://dx.doi.org/10.2174/138920306778018043 |
Print ISSN 1389-2037 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5550 |
11
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Chromosomal Translocations as Biomarkers in Leukemia Diagnosis and Pharmacogenomics
Recent Patents on Biomarkers Selected Players in the Inflammation Cascade and Drugs That Target These Inflammation Genes Against Metastasis
Anti-Cancer Agents in Medicinal Chemistry Selenium Compounds Biotransformed by Mushrooms: Not Only Dietary Sources, But Also Toxicity Mediators
Current Nutrition & Food Science miRNAs in Cancer Prevention and Treatment and as Molecular Targets for Natural Product Anticancer Agents
Current Cancer Drug Targets ADAM28 as a Target for Human Cancers
Current Pharmaceutical Design A Needle-Free Approach for Topical Immunization: Antigen Delivery via Vesicular Carrier System(s)
Current Medicinal Chemistry Vascular Endothelial Growth Factor and Vascular Endothelial Growth Factor Receptor Inhibitors as Anti-Angiogenic Agents in Cancer Therapy
Recent Patents on Anti-Cancer Drug Discovery Abscopal Effect of Radiation Therapy and Signal Transduction
Current Signal Transduction Therapy Therapeutic Potential and Outlook of Alternative Medicine for Osteoporosis
Current Drug Targets Tailored Angiogenesis Inhibition in Cancer Therapy: Respecting the Heart to Improve the Net Outcome
Current Signal Transduction Therapy MicroRNA Regulation of Androgen Receptor in Castration-Resistant Prostate Cancer: Premises, Promises, and Potentials
Current Molecular Pharmacology Targeting Type 1 Diabetes Before and at the Clinical Onset of Disease
Endocrine, Metabolic & Immune Disorders - Drug Targets Use of Cytokines in Cancer Vaccines/Immunotherapy: Recent Developments Improve Survival Rates for Patients with Metastatic Malignancy
Current Pharmaceutical Design Graphical Abstracts
Medicinal Chemistry Targeted Inhibition of Rictor/mTORC2 in Cancer Treatment: A New Era after Rapamycin
Current Cancer Drug Targets State of Art and Recent Developments of Anti-Cancer Strategies Based on TRAIL
Recent Patents on Anti-Cancer Drug Discovery Highly Selective MEK Inhibitors
Current Enzyme Inhibition TNFR1 Regulates Ovarian Cancer Cell Tumorigenicity Through PIK3CB-p110Beta
Current Molecular Medicine miR-15b and miR-21 as Circulating Biomarkers for Diagnosis of Glioma
Current Genomics Dual-Targeted Molecular Probes for Cancer Imaging
Current Pharmaceutical Biotechnology